Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
STZ causes depletion of immune cells in sciatic nerve and dorsal root ganglion in experimental diabetes.
J. Neuroimmunol. 306, 76-82 (2017)
DOI Verlagsversion bestellen
Streptozotocin (STZ) treatment, a common model for inducing diabetes in rodent models, induces thermal hyperalgesia and neuronal toxicity independently of hyperglycemia by oxidizing and activating TRPA1 and TRPV1. Following treatment with STZ, CD45+ immune cells were found to be depleted in sciatic nerve (SN) and DRG in mice, prior to hyperglycemia. Macrophages were also lost in DRG and NFκB-p65-activation was increased in SN macrophages. Immune cells were significantly reduced in both SN and DRG up to three weeks, post-treatment. Loss of PNS-resident macrophages in response to STZ-mediated toxicity may affect the regenerative capacity of the nerve in response to further injury caused by diabetes.
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Diabetic Neuropathy ; Experimental Diabetes ; Macrophage ; Neurotoxicity; Thermal Hyperalgesia; Scavenger-receptor; Sensitive Method; Spinal-cord; Streptozotocin; Macrophages; Neuropathy; Pain; Regeneration; Expression
ISSN (print) / ISBN 0165-5728
Zeitschrift Journal of Neuroimmunology
Quellenangaben Band: 306, Seiten: 76-82
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Cancer (IDC)